Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters

Database
Language
Journal
Affiliation country
Publication year range
1.
Retina ; 40(2): 345-349, 2020 Feb.
Article in English | MEDLINE | ID: mdl-31972805

ABSTRACT

PURPOSE: To investigate the levels of systemic heparanase, inflammatory markers, and coagulation factor activities in patients with retinal vein occlusion (RVO). METHODS: This prospective study included 18 patients with central RVO, 22 patients with branch RVO, and 40 patients with age-related cataract as the control group. Serum heparanase protein levels and activities were measured by ELISA and a heparan degrading enzyme assay kit, respectively. Serum levels of MMP-2, MMP-9, TLR-2, and TLR-4 were measured by ELISA kits. The activities of coagulation factors (V, VII, VIII, and IX) were determined with an autoanalyzer. The Mann-Whitney U test was used to compare the above parameters between patients with RVO and control subjects. The relationship between two of the above parameters was analyzed by Spearman's correlation. RESULTS: Patients with RVO had higher levels of systemic heparanase protein, heparanase activities, coagulation factors' (V, VIII, and IX) activities, MMP-2, MMP-9, TLR-2, and TLR-4 compared with the control group. Systemic heparanase levels were correlated with serum levels of MMP-2, MMP-9, TLR-2, TLR-4, and activities of coagulation factors VIII and IX. CONCLUSION: Increase of systemic heparanase in RVO is associated with activation of systemic inflammation and blood hypercoagulability.


Subject(s)
Blood Coagulation/physiology , Glucuronidase/blood , Inflammation/blood , Retinal Vein Occlusion/enzymology , Thrombophilia/complications , Biomarkers/blood , Case-Control Studies , Enzyme-Linked Immunosorbent Assay , Female , Humans , Inflammation/complications , Male , Middle Aged , Prospective Studies , Retinal Vein Occlusion/complications , Risk Factors , Thrombophilia/enzymology
SELECTION OF CITATIONS
SEARCH DETAIL